These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27129011)

  • 1. Pharmacokinetic interactions between topiramate and diltiazem, hydrochlorothiazide, or propranolol.
    Manitpisitkul P; Curtin CR; Shalayda K; Wang SS; Ford L; Heald D
    Clin Pharmacol Drug Dev; 2014 Sep; 3(5):378-87. PubMed ID: 27129011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steady-state pharmacokinetics of diltiazem and hydrochlorothiazide administered alone and in combination.
    Weir SJ; Dimmitt DC; Lanman RC; Morrill MB; Geising DH
    Biopharm Drug Dispos; 1998 Sep; 19(6):365-71. PubMed ID: 9737817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic interactions between topiramate and pioglitazone and metformin.
    Manitpisitkul P; Curtin CR; Shalayda K; Wang SS; Ford L; Heald D
    Epilepsy Res; 2014 Nov; 108(9):1519-32. PubMed ID: 25219351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of diltiazem and propranolol when administered alone and in combination.
    Dimmitt DC; Yu DK; Elvin AT; Giesing DH; Lanman RC
    Biopharm Drug Dispos; 1991 Oct; 12(7):515-23. PubMed ID: 1932613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic interactions of topiramate.
    Bialer M; Doose DR; Murthy B; Curtin C; Wang SS; Twyman RE; Schwabe S
    Clin Pharmacokinet; 2004; 43(12):763-80. PubMed ID: 15355124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic interactions of moricizine and diltiazem in healthy volunteers.
    Shum L; Pieniaszek HJ; Robinson CA; Davidson AF; Widner PJ; Benedek IH; Flamenbaum W
    J Clin Pharmacol; 1996 Dec; 36(12):1161-8. PubMed ID: 9013374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of atorvastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats.
    Hong SP; Chang KS; Choi DH; Choi JS
    Arch Pharm Res; 2007 Jan; 30(1):90-5. PubMed ID: 17328247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative steady-state pharmacokinetic evaluation of immediate-release topiramate and USL255, a once-daily extended-release topiramate formulation.
    Bialer M; Shekh-Ahmad T; Braun TL; Halvorsen MB
    Epilepsia; 2013 Aug; 54(8):1444-52. PubMed ID: 23692553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open-label drug-drug interaction study of the steady-state pharmacokinetics of topiramate and glyburide in patients with type 2 diabetes mellitus.
    Manitpisitkul P; Curtin CR; Shalayda K; Wang SS; Ford L; Heald DL
    Clin Drug Investig; 2013 Dec; 33(12):929-38. PubMed ID: 24132772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of propranolol on the disposition and negative dromotropic activity of diltiazem in the dog during multiple dosing.
    Maskasame C; Lankford SM; Bai SA
    Drug Metab Dispos; 1993; 21(1):156-61. PubMed ID: 8095211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic interaction between single oral doses of diltiazem and sirolimus in healthy volunteers.
    Böttiger Y; Säwe J; Brattström C; Tollemar J; Burke JT; Häss G; Zimmerman JJ
    Clin Pharmacol Ther; 2001 Jan; 69(1):32-40. PubMed ID: 11180036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hydrochlorothiazide on the pharmacokinetics, pharmacodynamics, and tolerability of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in healthy participants.
    Devineni D; Vaccaro N; Polidori D; Rusch S; Wajs E
    Clin Ther; 2014 May; 36(5):698-710. PubMed ID: 24726680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of diltiazem on the pharmacokinetics of propranolol, metoprolol and atenolol.
    Tateishi T; Nakashima H; Shitou T; Kumagai Y; Ohashi K; Hosoda S; Ebihara A
    Eur J Clin Pharmacol; 1989; 36(1):67-70. PubMed ID: 2917591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diltiazem and propranolol in mild to moderate essential hypertension as monotherapy or with hydrochlorothiazide.
    Massie B; MacCarthy EP; Ramanathan KB; Weiss RJ; Anderson M; Eidelson BA; Labreche DG; Tubau JF; Ulep D; Bartels D
    Ann Intern Med; 1987 Aug; 107(2):150-7. PubMed ID: 3300457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diltiazem pharmacokinetics in elderly volunteers after single and multiple doses.
    Caillé G; Boucher S; Spénard J; Lakhani Z; Russell A; Thiffault J; Grace MG
    Eur J Drug Metab Pharmacokinet; 1991; 16(2):75-80. PubMed ID: 1936076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic interaction study between eslicarbazepine acetate and topiramate in healthy subjects.
    Nunes T; Sicard E; Almeida L; Falcão A; Rocha JF; Brunet JS; Lefebvre M; Soares-da-Silva P
    Curr Med Res Opin; 2010 Jun; 26(6):1355-62. PubMed ID: 20377319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of food on the relative bioavailability of rapidly dissolving immediate-release solid oral products containing highly soluble drugs.
    Yu LX; Straughn AB; Faustino PJ; Yang Y; Parekh A; Ciavarella AB; Asafu-Adjaye E; Mehta MU; Conner DP; Lesko LJ; Hussain AS
    Mol Pharm; 2004; 1(5):357-62. PubMed ID: 16026005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate pharmacokinetics in children and adults with epilepsy: a case-matched comparison based on therapeutic drug monitoring data.
    Battino D; Croci D; Rossini A; Messina S; Mamoli D; Perucca E
    Clin Pharmacokinet; 2005; 44(4):407-16. PubMed ID: 15828853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous assay of propranolol, diltiazem and metabolites of diltiazem in human plasma by liquid chromatography.
    Ververs FF; Schaefer HG; Lefevre JF; Lopez LM; Derendorf H
    J Pharm Biomed Anal; 1990; 8(6):535-9. PubMed ID: 2093390
    [No Abstract]   [Full Text] [Related]  

  • 20. Steady-state dose proportionality of a once-a-day sustained-release diltiazem hydrochloride formulation in healthy subjects.
    Ziemniak J; Colligon I; Heald D
    Clin Ther; 1992; 14(2):158-65. PubMed ID: 1611640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.